Drug Profile
Interferon-alpha recombinant - SciVac Ltd
Alternative Names: SciFeronLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator SciGen
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Haematological disorders; Viral infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Singapore
- 04 Nov 2017 No recent reports of development identified for preclinical development in Haematological-disorders in Singapore
- 04 Nov 2017 No recent reports of development identified for preclinical development in Viral-infections in Singapore